Multitargeted therapy of cancer by green tea polyphenols

Cancer Letters

Volumn 269, Issue 2, 2008, Pages 269-280

  Khan, Naghma ^a   Mukhtar, Hasan ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Cancer; EGCG; Green tea polyphenols; Signal transduction

Indexed keywords

CATECHIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIGALLOCATECHIN GALLATE; GREEN TEA EXTRACT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; POLYPHENOL; PROTEASOME; SOMATOMEDIN C; TRANSCRIPTION FACTOR AP 1; UROKINASE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER THERAPY; CELL CYCLE ARREST; DRUG BIOAVAILABILITY; DRUG HALF LIFE; DRUG TRANSFORMATION; ENZYME INHIBITION; HUMAN; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; SHORT SURVEY; SIGNAL TRANSDUCTION; TEA; TIME TO MAXIMUM PLASMA CONCENTRATION;

ANIMALIA;

EID: 51549087131     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.04.014     Document Type: Review

References (86)

1. Mukhtar H., and Ahmad N. Cancer chemoprevention: future holds in multiple agents. Toxicol. Appl. Pharmacol. 158 (1999) 207-210
2. Khan N., and Mukhtar H. Tea polyphenols for health promotion. Life Sci. 81 (2007) 519-533
3. Khan W.A., Wang Z.Y., Athar M., Bickers D.R., and Mukhtar H. Inhibition of the skin tumorigenicity of (+/-)-7 beta,8 alpha-dihydroxy-9 alpha,10 alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene by tannic acid, green tea polyphenols and quercetin in Sencar mice. Cancer Lett. 42 (1988) 7-12
4. Khan N., Afaq F., and Mukhtar H. Cancer chemoprevention through dietary antioxidants: progress and promise. Antioxid. Redox Signal. 10 (2007) 475-510
5. Lambert J.D., and Yang C.S. Cancer chemopreventive activity and bioavailability of tea and tea polyphenols. Mutat. Res. 523-524 (2003) 201-208
6. Vaidyanathan J.B., and Walle T. Glucuronidation and sulfation of the tea flavonoid (-)-epicatechin by the human and rat enzymes. Drug Metab. Dispos. 30 (2002) 897-903
7. Lee M.J., Wang Z.Y., Li H., Chen L., Sun Y., Gobbo S., et al. Analysis of plasma and urinary tea polyphenols in human subjects. Cancer Epidemiol. Biomarkers Prev. 4 (1995) 393-399
8. Li C., Lee M.J., Sheng S., Meng X., Prabhu S., Winnik B., et al. Structural identification of two metabolites of catechins and their kinetics in human urine and blood after tea ingestion. Chem. Res. Toxicol. 13 (2000) 177-184
9. Meselhy M.R., Nakamura N., and Hattori M. Biotransformation of (-)-epicatechin 3-O-gallate by human intestinal bacteria. Chem. Pharm. Bull. (Tokyo) 45 (1997) 888-893
10. Lambert J.D., and Yang C.S. Mechanisms of cancer prevention by tea constituents. J. Nutr. 133 (2003) 3262S-3267S
11. Okushio K., Suzuki M., Matsumoto N., Nanjo F., and Hara Y. Identification of (-)-epicatechin metabolites and their metabolic fate in the rat. Drug Metab. Dispos. 27 (1999) 309-316
12. Kim S., Lee M.J., Hong J., Li C., Smith T.J., Yang G.Y., et al. Plasma and tissue levels of tea catechins in rats and mice during chronic consumption of green tea polyphenols. Nutr. Cancer 37 (2000) 41-48
13. Katiyar S.K., Afaq F., Azizuddin K., and Mukhtar H. Inhibition of UVB-induced oxidative stress-mediated phosphorylation of mitogen-activated protein kinase signaling pathways in cultured human epidermal keratinocytes by green tea polyphenol (-)-epigallocatechin-3-gallate. Toxicol. Appl. Pharmacol. 176 (2001) 110-117
14. Maeda-Yamamoto M., Suzuki N., Sawai Y., Miyase T., Sano M., Hashimoto-Ohta A., and Isemura M. Association of suppression of extracellular signal-regulated kinase phosphorylation by epigallocatechin gallate with the reduction of matrix metalloproteinase activities in human fibrosarcoma HT1080 cells. J. Agric. Food Chem. 51 (2003) 1858-1863
15. Deguchi H., Fujii T., Nakagawa S., Koga T., and Shirouzu K. Analysis of cell growth inhibitory effects of catechin through MAPK in human breast cancer cell line T47D. Int. J. Oncol. 21 (2002) 1301-1305
16. Bae J.Y., Choi J.S., Choi Y.J., Shin S.Y., Kang S.W., Han S.J., et al. (-)Epigallocatechin gallate hampers collagen destruction and collagenase activation in ultraviolet-B-irradiated 23 human dermal fibroblasts: Involvement of mitogen-activated protein kinase. Food Chem. Toxicol. 46 (2008) 1298-1307
17. Afaq F., Ahmad N., and Mukhtar H. Suppression of UVB-induced phosphorylation of mitogen-activated protein kinases and nuclear factor kappa B by green tea polyphenol in SKH-1 hairless mice. Oncogene 22 (2003) 9254-9264
18. Vayalil P.K., Elmets C.A., and Katiyar S.K. Treatment of green tea polyphenols in hydrophilic cream prevents UVB-induced oxidation of lipids and proteins, depletion of antioxidant enzymes and phosphorylation of MAPK proteins in SKH-1 hairless mouse skin. Carcinogenesis 24 (2003) 927-936
19. Chung H., Han J.H., Hwang E.J., Seo J.Y., Cho K.H., Kim K.H., et al. Dual mechanisms of green tea extract (EGCG)-induced cell survival in human epidermal keratinocytes. FASEB J. 17 (2003) 1913-1915
20. Eferl R., and Wagner E.F. AP-1: a double-edged sword in tumorigenesis. Nat. Rev. Cancer 3 (2003) 859-868
21. Kim H.S., Kim M.H., Jeong M., Hwang Y.S., Lim S.H., Shin B.A., et al. EGCG blocks tumor promoter-induced MMP-9 expression via suppression of MAPK and AP-1 activation in human gastric AGS cells. Anticancer Res. 24 (2004) 747-753
22. Dong Z., Ma W., Huang C., and Yang C.S. Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols, (-)-epigallocatechin gallate, and theaflavins. Cancer Res. 57 (1997) 4414-4419
23. Chen N.Y., Ma W.Y., Yang C.S., and Dong Z. Inhibition of arsenite-induced apoptosis and AP-1 activity by epigallocatechin-3-gallate and theaflavins. J. Environ. Pathol. Toxicol. Oncol. 19 (2000) 287-295
24. Richmond A., and B N.-k. chemokine gene transcription and tumour growth. Nat. Rev. Immunol. 2 (2002) 664-674
25. Aggarwal B.B., and Shishodia S. Suppression of the nuclear factor-kappaB activation pathway by spice-derived phytochemicals: reasoning for seasoning. Ann. NY Acad. Sci. 1030 (2004) 434-441
26. Kundu J.K., and Surh Y.J. Epigallocatechin gallate inhibits phorbol ester-induced activation of NF-kappa B and CREB in mouse skin: role of p38 MAPK. Ann. NY Acad. Sci. 1095 (2007) 504-512
27. Hong M.H., Kim M.H., Chang H.J., Kim N.H., Shin B.A., Ahn B.W., and Jung Y.D. (-)-Epigallocatechin-3-gallate inhibits monocyte chemotactic protein-1 expression in endothelial cells via blocking NF-kappaB signaling. Life Sci. 80 (2007) 1957-1965
28. Shin H.Y., Kim S.H., Jeong H.J., Kim S.Y., Shin T.Y., and Um J.Y. Epigallocatechin-3-gallate inhibits secretion of TNF-alpha, IL-6 and IL-8 through the attenuation of ERK and NF-kappaB in HMC-1 cell. Int. Arch. Allergy Immunol. 142 (2007) 335-344
29. Wheeler D.S., Catravas J.D., Odoms K., Denenberg A., Malhotra V., and Wong H.R. Epigallocatechin-3-gallate, a green tea-derived polyphenol, inhibits IL-1 beta-dependent proinflammatory signal transduction in cultured respiratory epithelial cell. J. Nutr. 134 (2004) 1039-1044
30. Hastak K., Gupta S., Ahmad N., Agarwal M.K., Agarwal M.L., and Mukhtar H. Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells. Oncogene 22 (2003) 4851-4859
31. Gupta S., Hastak K., Afaq F., Ahmad N., and Mukhtar H. Essential role of caspases in epigallocatechin-3-gallate-mediated inhibition of nuclear factor kappa B and induction of apoptosis. Oncogene 23 (2004) 2507-2522
32. Afaq F., Adhami V.M., Ahmad N., and Mukhtar H. Inhibition of ultraviolet B-mediated activation of nuclear factor kappaB in normal human epidermal keratinocytes by green tea Constituent (-)-epigallocatechin-3-gallate. Oncogene 22 (2003) 1035-1044
33. Syed D.N., Afaq F., Kweon M.H., Hadi N., Bhatia N., and Spiegelman V.S. Green tea polyphenol EGCG suppresses cigarette smoke condensate-induced NF-kappaB activation in normal human bronchial epithelial cells. Oncogene 26 (2007) 673-682
34. Yarden Y., and Sliwkowski M.X. Untangling the ErbB signalling network. Nat. Rev. Mol. Cell Biol. 2 (2001) 127-137
35. Masuda M., Suzui M., and Weinstein I.B. Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines. Clin. Cancer Res. 7 (2001) 4220-4229
36. Masuda M., Suzui M., Lim J.T., Deguchi A., Soh J.W., and Weinstein I.B. Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction. J. Exp. Ther. Oncol. 2 (2002) 350-359
37. Shimizu M., Deguchi A., Lim J.T., Moriwaki H., Kopelovich L., and Weinstein I.B. (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells. Clin. Cancer Res. 11 (2005) 2735-2746
38. Tachibana H., Koga K., Fujimura Y., and Yamada K. A receptor for green tea polyphenol EGCG. Nat. Struct. Mol. Biol. 11 (2004) 380-381
39. Adhami V.M., Siddiqui I.A., Ahmad N., Gupta S., and Mukhtar H. Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer. Cancer Res. 64 (2004) 8715-8722
40. Sachinidis A., Seul C., Seewald S., Ahn H., Ko Y., and Vetter H. Green tea compounds inhibit tyrosine phosphorylation of PDGF beta-receptor and transformation of A172 human glioblastoma. FEBS Lett. 471 (2000) 51-55
41. Liang Y.C., Lin-shiau S.Y., Chen C.F., and Lin J.K. Suppression of extracellular signals and cell proliferation through EGF receptor binding by (-)-epigallocatechin gallate in human A431 epidermoid carcinoma cells. J. Cell Biochem. 67 (1997) 55-65
42. Adachi S., Nagao T., Ingolfsson H.I., Maxfield F.R., Andersen O.S., Kopelovich L., et al. The inhibitory effect of (-)-epigallocatechin gallate on activation of the epidermal growth factor receptor is associated with altered lipid order in HT29 colon cancer cells. Cancer Res. 67 (2007) 6493-6501
43. Fu Y., and Chen A. The phyto-chemical (-)-epigallocatechin gallate suppresses gene expression of epidermal growth factor receptor in rat hepatic stellate cells in vitro by reducing the activity of Egr-1. Biochem. Pharmacol. 72 (2006) 227-238
44. Hou Z., Sang S., You H., Lee M.J., Hong J., Chin K.V., et al. Mechanism of action of (-)-epigallocatechin-3-gallate: auto-oxidation-dependent inactivation of epidermal growth factor receptor and direct effects on growth inhibition in human esophageal cancer KYSE 150 cells. Cancer Res. 65 (2005) 8049-8056
45. Sah J.F., Balasubramanian S., Eckert R.L., and Rorke E.A. Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway: Evidence for direct inhibition of ERK1/2 and AKT kinases. J. Biol. Chem. 279 (2004) 12755-12762
46. Masuda M., Suzui M., Lim J.T., and Weinstein I.B. Epigallocatechin-3-gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells. Clin. Cancer Res. 9 (2003) 3486-3491
47. Adhami V.M., Afaq F., and Mukhtar H. Insulin-like growth factor-I axis as a pathway for cancer chemoprevention. Clin. Cancer Res. 12 (2006) 5611-5614
48. Li M., He Z., Ermakova S., Zheng D., Tang F., Cho Y.Y., et al. Direct inhibition of insulin-like growth factor-I receptor kinase activity by (-)-epigallocatechin-3-gallate regulates cell transformation. Cancer Epidemiol. Biomarkers Prev. 16 (2007) 598-605
49. Adhami V.M., Malik A., Zaman N., Sarfaraz S., Siddiqui I.A., Syed D.N., et al. Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo. Clin. Cancer Res. 13 (2007) 1611-1619
50. Shimizu M., Deguchi A., Hara Y., Moriwaki H., and Weinstein I.B. EGCG inhibits activation of the insulin-like growth factor-1 receptor in human colon cancer cells. Biochem. Biophys. Res. Commun. 334 (2005) 947-953
51. Gupta S., Hastak K., Ahmad N., Lewin J.S., and Mukhtar H. Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc. Natl. Acad. Sci. USA 98 (2001) 10350-10355
52. Montagut C., Rovira A., and Albanell J. The proteasome: a novel target for anticancer therapy. Clin. Transl. Oncol. 8 (2006) 313-317
53. Nam S., Smith D.M., and Dou Q.P. Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo. J. Biol. Chem. 276 (2001) 13322-13330
54. Kuhn D., Lam W.H., Kazi A., Daniel K.G., Song S., Chow L.M., et al. Synthetic peracetate tea polyphenols as potent proteasome inhibitors and apoptosis inducers in human cancer cells. Front. Biosci. 10 (2005) 1010-1023
55. P.A. Konstantinopoulos, M.V. Karamouzis, A.G. Papatsoris, A.G. Papavassiliou, Matrix metalloproteinase inhibitors as anticancer agents, Int. J. Biochem. Cell Biol., doi:10.1016/j.biocel.2007.11.007.
56. Zhen M.C., Huang X.H., Wang Q., Sun K., Liu Y.J., Li W., et al. Green tea polyphenol epigallocatechin-3-gallate suppresses rat hepatic stellate cell invasion by inhibition of MMP-2 expression and its activation. Acta Pharmacol. Sin. 27 (2006) 1600-1607
57. Kim C.H., and Moon S.K. Epigallocatechin-3-gallate causes the p21/WAF1-mediated G(1)-phase arrest of cell cycle and inhibits matrix metalloproteinase-9 expression in TNF-alpha-induced vascular smooth muscle cells. Arch. Biochem. Biophys. 435 (2005) 264-272
58. Isemura M., Saeki K., Minami T., Hayakawa S., Kimura T., Shoji Y., et al. Inhibition of matrix metalloproteinases by tea catechins and related polyphenols. Ann. NY Acad. Sci. 878 (1999) 629-631
59. Garbisa S., Sartor L., Biggin S., Salvato B., Benelli R., and Albini A. Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin-3-gallate. Cancer 91 (2001) 822-832
60. Ho Y.C., Yang S.F., Peng C.Y., Chou M.Y., and Chang Y.C. Epigallocatechin-3-gallate inhibits the invasion of human oral cancer cells and decreases the productions of matrix metalloproteinases and urokinase-plasminogen activator. J. Oral Pathol. Med. 36 (2007) 588-593
61. Dass K., Ahmad A., Azmi A.S., Sarkar S.H., and Sarkar F.H. Evolving role of uPA/uPAR system in human cancers. Cancer Treat. Rev. 34 (2008) 122-136
62. Jankun J., Selman S.H., Swiercz R., and Skrzypczak-Jankun E. Why drinking green tea could prevent cancer. Nature 387 (1997) 561
63. Slivova V., Zaloga G., DeMichele S.J., Mukerji P., Huang Y.S., Siddiqui R., et al. Green tea polyphenols modulate secretion of urokinase plasminogen activator (uPA) and inhibit invasive behavior of breast cancer cells. Nutr. Cancer 52 (2005) 66-73
64. Siddiqui I.A., Malik A., Adhami V.M., Asim M., Hafeez B.B., Sarfaraz S., et al. Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis. Oncogene 27 (2007) 2055-2063
65. Ahmad N., Feyes D.K., Nieminen A.L., Agarwal R., and Mukhtar H. Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J. Natl. Cancer Inst. 89 (1997) 1881-1886
66. Khan N., Afaq F., Saleem M., Ahmad N., and Mukhtar H. Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer Res. 66 (2006) 2500-2505
67. Hastak K., Gupta S., Ahmad N., Agarwal M.K., Agarwal M.L., and Mukhtar H. Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells. Oncogene 22 (2003) 4851-4859
68. Leone M., Zhai D., Sareth S., Kitada S., Reed J.C., and Pellecchia M. Cancer prevention by tea polyphenols is linked to their direct inhibition of antiapoptotic Bcl-2-family proteins. Cancer Res. 63 (2003) 8118-8121
69. Lu Y.P., Lou Y.R., Li X.H., Xie J.G., Brash D., Huang M.T., et al. Stimulatory effect of oral administration of green tea or caffeine on ultraviolet light-induced increases in epidermal wild-type p53, p21(WAF1/CIP1), and apoptotic sunburn cells in SKH-1 mice. Cancer Res. 60 (2000) 4785-4791
70. Lu Y.P., Lou Y.R., Xie J.G., Peng Q.Y., Liao J., Yang C.S., et al. Topical applications of caffeine or (-)-epigallocatechin gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice. Proc. Natl. Acad. Sci. USA 99 (2002) 12455-12460
71. Liao J., Yang G.Y., Park E.S., Meng X., Sun Y., Jia D., et al. Inhibition of lung carcinogenesis and effects on angiogenesis and apoptosis in A/J mice by oral administration of green tea. Nutr. Cancer 48 (2004) 44-53
72. Gupta S., Hussain T., and Mukhtar H. Molecular pathway for (-)-epigallocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells. Arch. Biochem. Biophys. 410 (2003) 177-185
73. Gupta S., Ahmad N., Nieminen A.L., and Mukhtar H. Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (-)-epigallocatechin-3-gallate in androgen-sensitive and androgen-insensitive human prostate carcinoma cells. Toxicol. Appl. Pharmacol. 164 (2000) 82-90
74. Liang Y.C., Lin-Shiau S.Y., Chen C.F., and Lin J.K. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate. J. Cell Biochem. 75 (1999) 1-12
75. Bettuzzi S., Brausi M., Rizzi F., Castagnetti G., Peracchia G., and Corti A. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer Res. 66 (2006) 1234-1240
76. Jian L., Xie L.P., Lee A.H., and Binns C.W. Protective effect of green tea against prostate cancer: a case-control study in southeast China. Int. J. Cancer 108 (2004) 130-135
77. Zhang M., Holman C.D., Huang J.P., and Xie X. Green tea and the prevention of breast cancer: a case-control study in Southeast China. Carcinogenesis 28 (2007) 1074-1078
78. Nakachi K., Matsuyama S., Miyake S., Suganuma M., and Imai K. Preventive effects of drinking green tea on cancer and cardiovascular disease: epidemiological evidence for multiple targeting prevention. Biofactors 13 (2000) 49-54
79. Kurahashi N., Sasazuki S., Iwasaki M., Inoue M., and Tsugane S. Green tea consumption and prostate cancer risk in Japanese men: a prospective study. Am. J. Epidemiol. 167 (2008) 71-77
80. Sun C.L., Yuan J.M., Koh W.P., Yu M.C., and tea G. black tea and colorectal cancer risk: a meta-analysis of epidemiologic studies. Carcinogenesis 27 (2006) 1301-1309
81. Wu A.H., and Yu M.C. Tea, hormone-related cancers and endogenous hormone levels. Mol. Nutr. Food Res. 50 (2006) 160-169
82. Gao Y.T., McLaughlin J.K., Blot W.J., Ji B.T., Dai Q., and Fraumeni Jr. J.F. Reduced risk of esophageal cancer associated with green tea consumption. J. Natl. Cancer Inst. 86 (1994) 855-858
83. Imai K., Suga K., and Nakachi K. Cancer-preventive effects of drinking green tea among a Japanese population. Prev. Med. 26 (1997) 769-775
84. Jatoi A., Ellison N., Burch P.A., Sloan J.A., Dakhil S.R., Novotny P., et al. A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma. Cancer 97 (2003) 1442-1446
85. Fujiki H. Two stages of cancer prevention with green tea. J. Cancer Res. Clin. Oncol. 125 (1999) 589-597
86. Ahn W.S., Yoo J., Huh S.W., Kim C.K., Lee J.M., Namkoong S.E., et al. Protective effects of green tea extracts (polyphenon E and EGCG) on human cervical lesions. Eur. J. Cancer Prev. 12 (2003) 383-390